TrialJapanese journal of clinical oncology2017

Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma.

Akira Kawai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.